Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Adesis Inc is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:United States
Founded:2001
Employees:1,238
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval 9COYQN
EMA · #APR-22PD74VQ · 2020-06-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-Y6DOS6DJ
Issued: 2020-12-22
Expires: 2025-07-08
WHO GMP
World Health Organization
Cert #: CERT-TF03SM5Y
Issued: 2020-07-14
Expires: 2025-01-28
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-KSKX859C
Issued: 2020-09-06
Expires: 2025-08-24
Loading CDMO intelligence...
Key facts about Adesis Inc
- Adesis Inc is headquartered in the United States.
- Adesis Inc was founded in 2001.
- Adesis Inc has 1,238 employees.
- Adesis Inc's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Adesis Inc
Directory pages this company appears in, each with the full list of matching manufacturers.